Home

Magnetisch Prime Makellos tarnanas ioannis Schicksal Locken implizit

Greek Researcher Receives Top European Innovation Award (video)

Greek Researcher Receives Top European Innovation Award (video)

Ioannis Tarnanas - Worldwebforum

Ioannis Tarnanas - Worldwebforum

Ioannis Tarnanas - Worldwebforum

Ioannis Tarnanas - Worldwebforum

Ιωάννης Ταρνανάς | Cretalive

Ιωάννης Ταρνανάς | Cretalive

Alzheimer europe virtual museum

Alzheimer europe virtual museum

Ioannis Tarnanas's Page – iACToR

Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn

Evaluation of Three State-of-the-Art Classifiers for Recognition of Activities of Daily Living from Smart Home Ambient Data – topic of research paper in Medical engineering. Download scholarly article PDF and read for

Evaluation of Three State-of-the-Art Classifiers for Recognition of Activities of Daily Living from Smart Home Ambient Data – topic of research paper in Medical engineering. Download scholarly article PDF and read for

Ιωάννης Ταρνανάς: Ο Έλληνας ερευνητής που καινοτομεί στην πρώιμη διάγνωση του Αλτσχάιμερ [Συνέντευξη]

Ιωάννης Ταρνανάς: Ο Έλληνας ερευνητής που καινοτομεί στην πρώιμη διάγνωση του Αλτσχάιμερ [Συνέντευξη]

Ioannis Tarnanas - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com

Ioannis Tarnanas - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com

Ioannis Tarnanas (@ITarnanas) / Twitter

Ioannis Tarnanas (@ITarnanas) / Twitter

Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute

Ioannis Tarnanas's email & phone | Altoida's Founder email

Ioannis Tarnanas's email & phone | Altoida's Founder email

Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch

Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch

PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study

PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study

Ioannis Tarnanas - Worldwebforum

Ioannis Tarnanas - Worldwebforum

Ioannis Tarnanas - Worldwebforum

Ioannis Tarnanas - Worldwebforum

EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the

EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the

Ioannis Tarnanas (@ITarnanas) / Twitter

Ioannis Tarnanas (@ITarnanas) / Twitter

Ioannis Tarnanas presentations | SlideShare

Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Worldwebforum

Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Worldwebforum

2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT

2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT

Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED

Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED

Discover the venture case winners: A new way to fight Alzheimer`s disease and an insect-inspired micro-drone

Discover the venture case winners: A new way to fight Alzheimer`s disease and an insect-inspired micro-drone

Greek Researcher Receives Top European Innovation Award

Greek Researcher Receives Top European Innovation Award